Urinary tract infections in solid organ transplantation

American Journal of Transplantation

Volumn 13, Issue SUPPL.4, 2013, Pages 327-336

  Parasuraman, R ^a   Julian, K ^b  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Asymptomatic bacteriuria; candiduria; cystitis; pyelonephritis; transplantation; urinary tract infection; uropathogen

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; CEFIXIME; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; FOSFOMYCIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM; VORICONAZOLE;

ANTIMICROBIAL THERAPY; ARTICLE; ASYMPTOMATIC BACTERIURIA; CANDIDURIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTITIS; CYTOPENIA; DRUG ERUPTION; ECHOGRAPHY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LEUKOCYTE; LIVER TOXICITY; MICROBIOLOGY; NEPHROTOXICITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PYELONEPHRITIS; RECURRENT DISEASE; RISK FACTOR; URETHRITIS; URINARY TRACT INFECTION; UROSEPSIS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; HUMANS; ORGAN TRANSPLANTATION; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 84874919783     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12124     Document Type: Article

References (72)

1. Kahwaji J, Bunnapradist S, Hsu JW, Idroos ML, Dudek R,. Cause of death with graft function among renal transplant recipients in an integrated healthcare system. Transplantation 2011; 91: 225-230.
2. Parasuraman R, Abouljoud M, Jacobsen G, Reddy G, Koffron A, Venkat KK,. Increasing trend in infection-related death-censored graft failure in renal transplantation. Transplantation 2011; 91: 94-99.
3. Alangaden GJ, Thyagarajan R, Gruber SA, JM, et al. Infectious complications after kidney transplantation: Current epidemiology and associated risk factors. Clin Transplant 2006; 20: 401-409.
4. Alangaden G,. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep 2007; 9: 475-479.
5. Veroux M, Giuffrida G, Corona D, et al. Infective complications in renal allograft recipients: Epidemiology and outcome. Transplant Proc 2008; 40: 1873-1876.
6. Pelle G, Vimont S, Levy PP, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant 2007; 7: 899-907.
7. Abbott KC, Oliver JD, 3rd, Hypolite I, et al. Hospitalizations for bacterial septicemia after renal transplantation in the united states. Am J Nephrol 2001; 21: 120-127.
8. Parapiboon W, Ingsathit A, Disthabanchong S, et al. Impact of early ureteric stent removal and cost-benefit analysis in kidney transplant recipients: Results of a randomized controlled study. Transplant Proc 2012; 44: 737-739.
9. Lopez-Medrano F, Aguado JM,. Urinary tract infections in transplant recipients. Available from: http://www.antimicrobe.org/new/t32-dw.html.
10. Silva M, Jr., Marra AR, Pereira CA, Medina-Pestana JO, Camargo LF,. Bloodstream infection after kidney transplantation: Epidemiology, microbiology, associated risk factors, and outcome. Transplantation 2010; 90: 581-587.
11. Munoz P,. Management of urinary tract infections and lymphocele in renal transplant recipients. Clin Infect Dis 2001; 33(Suppl 1): S53-57.
12. Vidal E, Torre-Cisneros J, Blanes M, et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis 2012; 14: 595-603.
13. Abbott KC, Swanson SJ, Richter ER, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 2004; 44: 353-362.
14. Prograf. Revised May 2009; Available from: http://www.accessdata.fda.gov/ drugsatfda-docs/label/2009/050708s027,050709s021lbl.pdf.
15. Chuang P, Parikh CR, Langone A,. Urinary tract infections after renal transplantation: A retrospective review at two US transplant centers. Clin Transplant 2005; 1: 230-235.
16. Song JC, Hwang HS, Yoon HE, et al. Endoscopic subureteral polydimethylsiloxane injection and prevention of recurrent acute graft pyelonephritis. Nephron Clin Pract 2011; 117: c385-389.
17. Dupont PJ, Psimenou E, Lord R, Buscombe JR, Hilson AJ, Sweny P,. Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux. Transplantation 2007; 84: 351-355.
18. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-120.
19. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625-663.
20. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM,. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643-654.
21. Albert X, Huertas I, Pereiro, II, Sanfelix J, Gosalbes V, Perrota C,. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004: CD00 1209.
22. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE,. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15(Suppl 1): S216-227.
23. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE,. General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection. Taufkirchen, Germany: European Society of Clinical Microbiology and Infectious Diseases; 1993.
24. Kumazawa J, Matsumoto T,. Complicated urinary tract infections. In:, Bergan T, ed. Urinary tract infections. New York: Karger, 1997, pp. 19-26.
25. Grabe M, Bjerklund-Johansen TE, Botto H, et al. Guidelines on urological infections. 2012; Available from: http://www.uroweb.org/gls/pdf/17- Urological%20infections-LR%20II.pdf.
26. Keven K, Sahin M, Kutlay S, et al. Immunoglobulin deficiency in kidney allograft recipients: Comparative effects of mycophenolate mofetil and azathioprine. Transpl Infect Dis 2003; 5: 181-186.
27. Dantas SR, Kuboyama RH, Mazzali M, Moretti ML,. Nosocomial infections in renal transplant patients: Risk factors and treatment implications associated with urinary tract and surgical site infections. J Hosp Infect 2006; 63: 117-123.
28. Lapchik MS, Castelo Filho A, Pestana JO, Silva Filho AP, Wey SB,. Risk factors for nosocomial urinary tract and postoperative wound infections in renal transplant patients: A matched-pair case-control study. J Urol 1992; 147: 994-998.
29. Safdar N, Slattery WR, Knasinski V, et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis 2005; 40: 1413-1421.
30. Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK,. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis 2006; 8: 140-147.
31. Giral M, Pascuariello G, Karam G, et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int 2002; 61: 1880-1886.
32. Fayek SA, Keenan J, Haririan A, et al. Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: A large single center experience. Transplantation 2012; 93: 304-308.
33. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55 (4): 752-756; discussion 756-757.
34. Memikoglu KO, Keven K, Sengul S, Soypacaci Z, Erturk S, Erbay B,. Urinary tract infections following renal transplantation: A single-center experience. Transplant Proc 2007; 39: 3131-3134.
35. Di Cocco P, Orlando G, Mazzotta C, et al. Incidence of urinary tract infections caused by germs resistant to antibiotics commonly used after renal transplantation. Transplant Proc 2008; 40: 1881-1884.
36. Saemann M, Horl WH,. Urinary tract infection in renal transplant recipients. Eur J Clin Invest 2008; 38(Suppl 2): 58-65.
37. Lopez-Medrano F, Garcia-Bravo M, Morales JM, et al. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: An underdiagnosed etiology for obstructive uropathy and graft dysfunction-results of a prospective cohort study. Clin Infect Dis 2008; 46: 825-830.
38. Ison MG,. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43: 331-339.
39. Camara B, Mouzin M, Ribes D, et al. Perihepatitis and perinephric abscess due to Mycoplasma hominis in a kidney transplant patient. Exp Clin Transplant 2007; 5: 708-709.
40. Eilers E, Moter A, Bollmann R, Haffner D, Querfeld U,. Intrarenal abscesses due to Ureaplasma urealyticum in a transplanted kidney. J Clin Microbiol 2007; 45: 1066-1068.
41. Fisher JF, Sobel JD, Kauffman CA, Newman CA,. Candida urinary tract infections-treatment. Clin Infect Dis 2011; 52(Suppl 6): S457-466.
42. Green H, Rahamimov R, Gafter U, Leibovitci L, Paul M,. Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis 2011; 13: 441-447.
43. Rafat C, Vimont S, Ancel PY, et al. Ofloxacin: New applications for the prevention of urinary tract infections in renal graft recipients. Transpl Infect Dis 2011; 13: 344-352.
44. El, Amari EB, Hadaya K, Buhler L, et al. Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients. Nephrol Dial Transplant 2011; 26: 4109-4114.
45. Linares L, Cervera C, Cofan F, et al. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc 2007; 39: 2222-2224.
46. Pinheiro HS, Mituiassu AM, Carminatti M, Braga AM, Bastos MG,. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients. Transplant Proc 2010; 42: 486-487.
47. Hammami S, Boutiba-Ben Boubaker I, Ghozzi R, Saidani M, Amine S, Ben Redjeb S,. Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in a kidney transplantation unit. Diagn Pathol 2011; 6: 106.
48. Rice JC, Peng T, Kuo YF, et al. Renal allograft injury is associated with urinary tract infection caused by Escherichia coli bearing adherence factors. Am J Transplant 2006; 6: 2375-2383.
49. Goya N, Takahashi K, Tanabe K, et al. [Clinical studies of bacteriuria in renal transplantation recipients. Correlation with pyuria and symptomatic genitourinary tract infection]. Nihon Hinyokika Gakkai Zasshi 1991; 82: 947-954.
50. Ciszek M, Paczek L, Bartlomiejczyk I, Mucha K,. Urine cytokines profile in renal transplant patients with asymptomatic bacteriuria. Transplantation 2006; 81: 1653-1657.
51. Muller V, Becker G, Delfs M, Albrecht KH, Philipp T, Heemann U,. Do urinary tract infections trigger chronic kidney transplant rejection in man ? J Urol 1998; 159: 1826-1829.
52. Kumar D, Humar A, American Society of Transplantation. AST handbook of transplant infections. Hoboken, NJ: Blackwell, 2011.
53. Moradi M, Abbasi M, Moradi A, Boskabadi A, Jalali A,. Effect of antibiotic therapy on asymptomatic bacteriuria in kidney transplant recipients. Urol J 2005; 2: 32-35.
54. Griffin PJ, Salaman JR,. Urinary tract infections after renal transplantation: Do they matter? Br Med J 1979; 1: 710-711.
55. Green H, Rahamimov R, Goldberg E, et al. Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: Retrospective observational study. Eur J Clin Microbiol Infect Dis 2012: Aug 25 [Epub ahead of print].
56. Kumar D, Humar A,. Infections in kidney transplant recipients. In:, Bowden RA, Ljungman P, Snydman DR, eds. Transplant infections. 3rd Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2010, pp. 138-149.
57. Mitra S, Alangaden GJ,. Recurrent urinary tract infections in kidney transplant recipients. Curr Infect Dis Rep 2011; 13: 579-587.
58. Pappas PG, Silveira FP,. Candida in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4): S173-179.
59. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38: 161-189.
60. Jung GO, Chun JM, Park JB, Choi GS, Kwon CH, Joh JW, et al. Clinical significance of posttransplantation vesicoureteral reflux during short-term period after kidney transplantation. Transplant Proc 2008; 40: 2339-2341.
61. Wang CH, Fang CC, Chen NC, et al. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: A systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172: 988-996.
62. John U, Kemper MJ,. Urinary tract infections in children after renal transplantation. Pediatr Nephrol 2009; 24: 1129-1136.
63. Yansouni CP, Dendukuri N, Liu G, et al. Positive cultures of organ preservation fluid predict postoperative infections in solid organ transplantation recipients. Infect Control Hosp Epidemiol 2012; 33: 672-680.
64. Hoy WE, Kissel SM, Freeman RB, Sterling WA, Jr., Altered patterns of posttransplant urinary tract infections associated with perioperative antibiotics and curtailed catheterization. Am J Kidney Dis 1985; 6: 212-216.
65. Fox BC, Sollinger HW, Belzer FO, Maki DG,. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: Clinical efficacy, absorption of trimethoprim- sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990; 89: 255-274.
66. Multiply antibiotic-resistant gram-negative bacteria. Am J Transplant 2004; 4(Suppl 10): 21-24.
67. Killgore KM, March KL, Guglielmo BJ,. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 2004; 38: 1148-1152.
68. Batiuk TD, Bodziak KA, Goldman M,. Infectious disease prophylaxis in renal transplant patients: A survey of US transplant centers. Clin Transplant 2002; 16: 1-8.
69. Hibberd PL, Tolkoff-Rubin NE, Doran M, et al. Trimethoprim- sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial. [ Online] J Curr Clin Trials 1992 August 11; Doc. No. 15.
70. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl 3): S1-155.
71. Tavakoli A, Surange RS, Pearson RC, Parrott NR, Augustine T, Riad HN,. Impact of stents on urological complications and health care expenditure in renal transplant recipients: Results of a prospective, randomized clinical trial. J Urol 2007; 177: 2260-2264; discussion 2264.
72. Tolkoff-Rubin NE, Cosimi AB, Russell PS, Rubin RH,. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis 1982; 4: 614-618.